restor3d, a North Carolina Orthopedic care tech startup specializing in developing personalized 3D-printed orthopedic implants, has secured $70M financing to accelerate its growth and innovation and maximize patients’ outcomes.
According to the company’s announcement on Wednesday, June 5, it raised $55M in a series A funding round led by Summers Value Partners and an additional $15M in debt financing spearheaded by Trinity Capital, bringing the total investment to $70M.
The latest investment will support the company’s growth and advancements in many key areas, including 3D printing technologies, software, AI-based automation, and medical education.
As part of the announcement, restor3d will introduce a new patient-specific implant system tailor-made for total ankle and shoulder replacements, offering 3D-printed orthopedic care solutions that fit the patient’s unique anatomy and pathology.
Restor3d is also looking to continue making advancements in other medical products, including a porous press-fit knee designed using its 3D printing technology for femoral and tibial components.
New Capital for Growth and Expansion
With a mission to deliver novel personalized medical solutions, the company’s investments in advanced 3D printing technologies will expand its in-house ‘powder to sterile product’ environment, shortening the delivery time of personalized implants while also reducing the production cost.
According to the announcement, the new capital infusion will also help Restor3d invest more in software and AI-backed automation solutions. Part of the capital will be channeled toward developing revolutionary software and automation technology to decrease lead times and support the company’s progressive growth.
The new funding will also support Restor3d’s advanced medical training and educational initiatives, which aim to equip surgeons and sales teams with critical training on the latest in orthopedic care, including surgical techniques and technology in reconstructive and orthopedic surgery.
According to restor3d CEO Kurt Jacobus, the latest investments signal investors’ confidence in the company’s vision and potential to transform personalized care with patient-specific 3d printed implants.
